Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,720.00
(
0.00%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
105.86
(
1.36%
)
Bitcoin
70,860.18
(
1.38%
)
News Focus
News Focus
Post# of 515740
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

boi568

Send PM Follow Ignore
Followers 59
Posts 7287
Boards Moderated 0
Alias Born 07/03/2020

boi568

Re: DrJan post# 472876

Friday, 11/01/2024 5:25:31 PM

Friday, November 01, 2024 5:25:31 PM

Post# of 515740
The transient side effects reported in the 2b/3 do not rise to the level of "important safety issues," so you can relax about that.

Nor has the administration of blarcamesine ever resulted in safety issues across multiple indications, wide age ranges, and in longitudinal studies.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • Mar 19, 2026 12:45 PM

ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM

Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM

ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM

ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM

Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM

Start posting your company's news
Only $200 per official company press release!